The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
New IMS/IMWG risk criteria by next-generation sequencing (NGS): Analysis of daratumumab benefit in both high- and standard-risk patients (pts) in the PERSEUS study.
 
Luca Bertamini
No Relationships to Disclose
 
Carolina Terragna
No Relationships to Disclose
 
Niccolo Bolli
Honoraria - Amgen; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Menarini; Oncopeptides; Pfizer; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Pfizer; Takeda
Research Funding - Janssen
Travel, Accommodations, Expenses - Janssen
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
 
Paula Rodríguez-Otero
Consulting or Advisory Role - Abbvie; AstraZeneca; BMS; GlaxoSmithKline; H3 Biomedicine; Johnson and Johnson; Menarini Steamline; Oncopeptides; Pfizer; Roche; Sanofi
Speakers' Bureau - Abbvie; BMS; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Johnson and Johnson; Menarini Steamline; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Mario Boccadoro
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Janssen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst)
 
Joan Blade
No Relationships to Disclose
 
Niels van de Donk
Consulting or Advisory Role - Abbvie (Inst); Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Galapagos NV (Inst); Janssen (Inst); Kite, a Gilead company (Inst); MERCK (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Francesca Gay
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Kite, a Gilead Company; Menarini; Oncopeptides; Regeneron; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Kite, a Gilead Company; Menarini; Oncopeptides; Regeneron; Roche; Sanofi; Takeda
 
Roberto Mina
Consulting or Advisory Role - Bristol-Myers Squibb; F. Hoffmann LaRoche; GlaxoSmithKline; Janssen; Pfizer; Regeneron; Takeda
Speakers' Bureau - Abbvie; Amgen
 
Aurore Perrot
Honoraria - Abbvie; Adaptive Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Therapeutics; Amgen; Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Sanofi
 
P. Joy Ho
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Johnson & Johnson/Janssen; Pfizer
Research Funding - Novartis
Travel, Accommodations, Expenses - Gilead Sciences; Johnson & Johnson/Janssen
 
Annemiek Broijl
Consulting or Advisory Role - Amgen; Johnson & Johnson; Pfizer; Sanofi
 
Meral Beksaç
Consulting or Advisory Role - BMS Turkey (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Oncopeptides (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
Speakers' Bureau - BMS Turkey (Inst); Menarini (Inst); Sanofi (Inst); Takeda (Inst)
 
Mark van Duin
No Relationships to Disclose
 
Diego Vieyra
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Pfizer (I)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Fredrik Borgsten
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Honoraria - Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson
 
Melissa Rowe
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda
 
Pieter Sonneveld
Leadership - European Myeloma Network
Consulting or Advisory Role - Amgen; CARsgen Therapeutics; Celgene; Janssen; Karyopharm Therapeutics
Research Funding - Amgen (Inst); BMS (Inst); Janssen (Inst); Skyline Diagnostics (Inst)